MedAdvisor Ltd (ASX: MDR) Share Price and News

Price

$0.087

Movement

0.003 (+3.57%)

as at 23 May - Closed (20 mins delayed)

52 Week Range

$0.082 - $0.59

 
1 Year Return

-77.69%

MedAdvisor Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $54.36 million
P/E Ratio 107.69
Dividend Yield 0.00%
Shares Outstanding 624.79 million
Earnings per share -0.009
Dividend per share N/A
Year To Date Return -62.67%
Earnings Yield 0.93%
Franking -
Share Price

$0.087

Day Change

0.003 (+3.57%)

52 Week Range

$0.082 - $0.59

Yesterday's Close

$0.084

Today's Open

$0.085

Days Range

$0.082 - $0.088

Volume

809,551

Avg. Volume (1 month)

839,276

Turnover

$69,244

as at 23 May - Closed

MedAdvisor Ltd (ASX: MDR)
Latest News

a smiling doctor looks at her computer screen with medical imaging X-rays on a light screen in the background.
Share Gainers

Why the MedAdvisor (ASX:MDR) share price jumped 9% on Friday

The MedAdvisor Ltd (ASX:MDR) share price was a strong performer on Friday and jumped as much as 9% higher. Here's…

Read more »

Share Market News

MedAdvisor Ltd (ASX:MDR) share price halted ahead of transformational $49 million acquisition

The MedAdvisor Ltd (ASX:MDR) share price is in a trading halt as it prepares to make a transformation acquisition...

Read more »

Digitised heart rate and share price chart with man on ipad in background signifying share price
Speculative

3 small cap ASX healthcare shares to watch closely in the 2020s

Here's why I think Volpara Health Technologies Ltd (ASX:VHT) and these ASX small cap healthcare shares are worth watching...

Read more »

CSL share price Digitised bubbles of cells representing ASX biotech shares such as CSL
Share Market News

Add these 3 ASX medical technology companies to your watch list

The global medical technology industry is worth some US$430 billion. These 3 ASX medical technology companies have promising futures.

Read more »

Speculative

3 exciting small cap ASX healthcare shares to watch

Could these small cap ASX healthcare shares be the next Ramsay Health Care Limited (ASX:RHC) and Cochlear Limited (ASX:COH)?

Read more »

Speculative

3 exciting small cap ASX shares to watch very closely

Medadvisor Ltd (ASX:MDR) and these small cap ASX shares could be destined for big things in the future. Here's why I…

Read more »

Speculative

3 exciting small cap ASX healthcare shares to watch

Volpara Health Technologies Ltd (ASX:VHT) and these small cap ASX healthcare shares could be worth adding to your watchlist...

Read more »

Speculative

3 exciting ASX healthcare shares to watch in the 2020s

Volpara Health Technologies Ltd (ASX:VHT) and these small cap ASX shares are making waves in the healthcare sector and need to…

Read more »

ASX Shares

3 small cap ASX healthcare shares with enormous potential

Could these small cap ASX healthcare shares be the next Cochlear Limited (ASX:COH) and Ramsay Health Care Limited (ASX:RHC)?

Read more »

a woman
Coronavirus News

Coronavirus: This ASX tech share is rocketing higher after telehealth launch

The MedAdvisor Ltd (ASX:MDR) share price is rocketing higher after announcing the launch of a telehealth service to combat the…

Read more »

a woman
Coronavirus News

Why this ASX medical tech share is up 22% today

The Medadvisor Ltd (ASX: MDR) share price has soared today after the ASX medical technology company announced it was launching…

Read more »

a woman
Share Market News

Why this ASX medical technology share surged 43% higher today

The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role…

Read more »

MDR ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
20th May 2025 2025-05-20T16:34:17 Ceasing to be a substantial holderYesNo4:34pm7208k
19th May 2025 2025-05-19T10:02:21 Application for quotation of securities - MDRYesNo10:02am717k
16th May 2025 2025-05-16T14:34:54 Notice of change of interests of substantial holder from EBOYesNo2:34pm3184k
15th May 2025 2025-05-15T08:39:19 Application for quotation of securities - MDRYesNo8:39am616k
15th May 2025 2025-05-15T08:24:34 Successful Completion of Share Purchase PlanYesNo8:24am360k
9th May 2025 2025-05-09T09:57:36 Strategic Review Update - Further InformationYesNo9:57am4106k
7th May 2025 2025-05-07T11:48:14 Trading HaltYesNo11:48am2474k
7th May 2025 2025-05-07T10:52:33 Pause in TradingYesNo10:52am1118k
7th May 2025 2025-05-07T08:38:38 Evaluation of Strategic Options UpdateYesNo8:38am265k
2nd May 2025 2025-05-02T17:58:18 Reinstatement to Official QuotationYesNo5:58pm1105k

About MedAdvisor Ltd

MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.

MDR Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
22 May 2025 $0.08 $0.00 0.00% 16,383 $0.09 $0.09 $0.08
21 May 2025 $0.09 $0.00 0.00% 1,301,128 $0.09 $0.09 $0.08
20 May 2025 $0.09 $0.00 0.00% 877,321 $0.09 $0.09 $0.09
19 May 2025 $0.09 $0.00 0.00% 914,778 $0.09 $0.09 $0.09
16 May 2025 $0.09 $0.00 0.00% 3,708,921 $0.09 $0.09 $0.09
15 May 2025 $0.09 $0.00 0.00% 1,138,928 $0.10 $0.10 $0.09
14 May 2025 $0.10 $-0.01 -10.00% 1,030,098 $0.10 $0.10 $0.10
13 May 2025 $0.10 $0.00 0.00% 30,588 $0.10 $0.10 $0.10
12 May 2025 $0.10 $0.00 0.00% 936,203 $0.10 $0.11 $0.10
09 May 2025 $0.10 $-0.03 -23.08% 3,806,463 $0.14 $0.14 $0.09
07 May 2025 $0.13 $0.03 30.00% 1,195,245 $0.14 $0.17 $0.13
06 May 2025 $0.10 $0.01 10.64% 319,382 $0.10 $0.10 $0.10
05 May 2025 $0.09 $0.00 0.00% 1,923,275 $0.10 $0.10 $0.09
23 Apr 2025 $0.10 $0.00 0.00% 426,073 $0.09 $0.10 $0.09

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
14 Nov 2024 Richard (Rick) Ratliff Issued 760,059 $220,417
Issue of options.
30 Oct 2024 Lucas Merrow Expiry 750,000 $262,500
Options expired.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Catherine (Kate) Jane Hill Non-Executive Director May 2023
Ms Hill is auditor and business advisor with over 30 years of experience of working with privately owned and ASX-listed companies across a range of business issues. A former senior partner and first female board member of top 4 accounting firm Deloitte, she has in recent years turned her focus, her energies, and experience into Non-Executive Director roles. She is a director of small to mid-cap companies listed on ASX and other global exchanges, with a track record in change involving new business models, new markets, and new technologies. She is chair of Risk Committee and member of People Committee.
Mr Jim Xenos Non-Executive Director Nov 2015
Mr Xenos is currently the Chief Executive Officer of NostraData Pty Limited, which he co-founded in 2010. Prior to co-founding NostraData, Jim held several Associate Director positions with GlaxoSmithKline PLC. Jim was also the Head of Retail at Sigma Healthcare Limited for Herron Pharmaceuticals. She is Chair of people committee.
Mr Lucas Merrow Non-Executive Director Aug 2021
Mr Merrow co-founded and served as the Chief Executive Officer of Eliza Corporation-the leader in health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the Chief Operating Officer of Adheris Health, a leading firm in prescription adherence and patient education programs in the United States. MedAdvisor acquired Adheris Health in November 2020. He is Member of People Committee.
Mr Richard (Rick) Ratliff Chief Executive OfficerManaging Director Jul 2022
Mr Ratliff spent over 30 years in the healthcare and pharmaceutical technology sector in key markets in which MedAdvisor Solutions operates. He has led the development of several large-scale technology-enabled healthcare businesses within global organizations such as IBM and Accenture as well as via start-up and early-stage businesses, including Healthvision, Surescripts, and ConnectiveRx. Rick also worked with the Australian federal government to develop and deliver My Health Record, the leading online EHR available to all Australian citizens. He is a member of People Committee.
Mr Kevin Hutchinson Non-Executive Director Nov 2022
Mr Hutchinson is an entrepreneur with 30 years of experience in the tech industry. He has built and grown companies that deliver innovative services by using disruptive technology. He also has seen great success in his ability to accelerate growth by hiring and developing teams that drive exceptional results. He has served in numerous C-level executive roles, including CEO and COO, as well as several non-executive board appointments. Kevin is CEO and Director of AXL Health and on the Board of Matrix Analytics dba eon Health. He is a member of Risk Committee.
Ms Gillian Maria Nairn Joint Company Secretary Dec 2024
-
Ms Ancila Desai Chief Financial OfficerCompany Secretary Feb 2023
-
Ancila Desai Chief Financial OfficerCompany Secretary
-
Gillian Maria Nairn Joint Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Guild Group Holdings Limited 94,905,130 17.21%
HSBC Custody Nominees (Australia) Limited 84,152,463 15.26%
Ebos Ph Pty Ltd 53,986,823 9.79%
J P Morgan Nominees Australia Pty Limited 45,226,380 8.20%
Cotiviti Inc 43,999,999 7.98%
Citicorp Nominees Pty Limited 38,361,455 6.96%
National Nominees Limited 14,892,708 2.70%
UBS Nominees Pty Ltd 14,289,149 2.59%
Bond Street Custodians Limited <Salter - D79836 A/C> 9,700,000 1.76%
Kojent Pty Ltd <Kojent A/C> 6,846,956 1.24%
Indcorp Consulting Group Pty Limited <Superannuation Fund A/C> 6,550,000 1.19%
Romida Enterprises Pty Ltd <Romida Family A/C> 5,642,935 1.02%
Gread Management Pty Limited <The A G & R R Family A/C> 5,344,283 0.97%
Provare Pty Ltd <Provare Investment A/C> 3,743,419 0.68%
Tagdime Pty Ltd <Ian M Davison P/L S/F A/C> 3,264,316 0.59%
Dr Christopher Harold Benton 3,000,000 0.54%
BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 2,815,940 0.51%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 2,383,158 0.43%
Dmx Capital Partners Limited 2,351,551 0.43%
Wavey Industries Pty Ltd <Josh Swinnerton Family A/C> 2,300,000 0.44%

Profile

since

Note